H.B. Fuller Reports Fourth Quarter and Fiscal Year 2022 Results
H.B. Fuller Company (NYSE: FUL) reported strong financial results for fiscal year 2022, with net revenue increasing by 14% to $3.75 billion, and adjusted EPS rising 15% to $4.00 per share. Despite challenges, including unfavorable foreign currency impacts reducing adjusted EPS by approximately 16%, the company experienced significant growth in adjusted EBITDA, reaching $530 million. For Q4 2022, net revenue was $958 million, a 7% year-on-year increase. However, the fourth quarter also reflected a slowdown in demand for Construction Adhesives and losses due to inflation and currency translation. The fiscal 2023 outlook predicts adjusted EBITDA of $580 million to $610 million and flat to a 3% revenue decline.
- Net revenue for fiscal year 2022 increased by 14% to $3.75 billion.
- Adjusted EPS rose to $4.00, up 15% compared to the previous year.
- Adjusted EBITDA grew by 14% to $530 million, supported by strong pricing execution.
- Cash flow from operations increased by 20% to $257 million.
- Unfavorable foreign currency exchange reduced adjusted EPS by approximately $0.56, or 16%.
- Q4 2022 saw a significant slowdown in demand for Construction Adhesives.
- Adjusted EPS in Q4 2022 was down slightly year-on-year due to raw material inflation and higher interest expenses.
Fiscal Year 2022 Noteworthy Items:
-
Net revenue of
, up$3.75 billion 14% versus fiscal year 2021; organic revenue up17% year-on-year, driven by responsibly strong pricing execution; -
Net income of
or$180 million per share (diluted); adjusted EPS of$3.26 per share (diluted), up$4.00 15% year-on-year; unfavorable foreign currency exchange reduced adjusted EPS by approximately , or$0.56 16% versus the prior year; -
Adjusted EBITDA of
, up$530 million 14% year-on-year on pricing gains and strong execution, more than overcoming significant year-on-year raw material inflation and unfavorable foreign currency impacts; -
Cash flow from operations of
, up$257 million 20% year-on-year; -
As a reminder, there was one additional reporting week in fiscal year 2022, which positively impacted net revenue and adjusted EBITDA growth versus 2021 by approximately
2% for the year and7.5% for the fourth quarter; the definition of organic growth excludes the impact of the extra week.
Fourth Quarter 2022 Noteworthy Items:
-
Net revenue of
, up$958 million 7% year-on-year; organic revenue increased6% year-on-year, driven by strong organic growth in both Hygiene, Health, and Consumable and Engineering Adhesives and solid pricing execution in all three GBUs; -
Net Income was
; adjusted EBITDA of$48 million was up$141 million 5% year-on-year and adjusted EBITDA margin was14.7% ; -
Reported EPS (diluted) was
; adjusted EPS (diluted) was$0.87 , down slightly versus the prior year due to raw material inflation, higher interest expense and unfavorable foreign currency exchange impacts; unfavorable foreign currency exchange reduced adjusted EPS in the quarter by approximately$1.04 , or$0.22 20% versus the prior year; -
Net working capital, as a percentage of annualized net revenue, decreased 100 basis points sequentially from
18.9% in the third quarter to17.9% in the fourth quarter; - Net debt-to-adjusted EBITDA ratio declined sequentially from 3.6X to 3.2X driven by improved cash flow from operations and growth in adjusted EBITDA.
Fiscal Year 2022 Summary:
Net revenue for fiscal year 2022 was
Net income attributable to
Summary of Fourth Quarter 2022 Results:
Net revenue for the fourth quarter of fiscal 2022 was
Gross profit in the fourth quarter of fiscal 2022 was
Selling, general and administrative (SG&A) expense was
Net income attributable to
Adjusted EBITDA in the fourth quarter of fiscal 2022 was
“We delivered double-digit growth in organic revenue, adjusted EBITDA, and adjusted EPS in fiscal year 2022, driven by market share gains, appropriately strong pricing actions, and improved execution,” said
“At the same time, we recognize that we did not finish the year as strong as we had expected. During the fourth quarter, we experienced a more pronounced and accelerated slowdown in demand for Construction Adhesives than we anticipated, which was driven by customer inventory de-stocking actions prior to the end of the calendar year. Additionally, we experienced unexpected softness in
“As we look to the year ahead, we expect global economic conditions to remain slow and we are prepared to control expenses, expand margins by continuing to innovate for our customers and benefiting from scale with our suppliers, and grow cash flow in such an environment. We have managed pricing well in the face of unprecedented raw material inflation and we have the tools and capabilities to drive profit growth and meaningful margin expansion going forward.
“We are confident and optimistic in our ability to drive organic growth, expand EBITDA margin, and grow EBITDA at a rate consistent with our long-term financial goal of annual double-digit EBITDA growth. We have many competitive advantages to leverage in the current economic environment. In addition to our ability to collaboratively innovate with customers to serve their needs, we have pricing analytics and discipline, robust product substitution capabilities, and a track record of executing nimbly. I have great confidence in our strategy, and I see tremendous potential for continued strong financial performance.”
Balance Sheet and Cash Flow Items:
At the end of the fourth quarter of fiscal 2022 net debt was
Net working capital in the fourth quarter of fiscal 2022 declined
Fiscal 2023 Outlook:
-
Adjusted EBITDA for fiscal 2023 is expected to be in the range of
to$580 million , equating to growth of approximately$610 million 9% to15% versus fiscal year 2022; -
Revenue for 2023 is expected to be flat to down
3% versus 2022; organic revenue growth for fiscal year 2023 is expected to be in the range of2% to4% , adjusting for the impact of the extra week in fiscal year 2022; -
Fiscal year 2023 will be a 52-week year compared to a 53-week year in fiscal year 2022, which will unfavorably impact year-on-year net revenue and adjusted EBITDA growth by approximately
2% in fiscal year 2023; -
Foreign currency translation is expected to unfavorably impact net revenue growth by between
3% to4% in fiscal year 2023, with the first half of the year being more heavily impacted given the significant strengthening of theU.S. dollar that occurred in the second half of fiscal year 2022; -
The core tax rate, excluding the impact of discrete items, is anticipated to be between
27% and29% in fiscal year 2023; -
Net interest expense for fiscal 2023 is expected to be between
and$115 million , up from fiscal year 2022, reflecting higher interest rates;$125 million -
Adjusted EPS in fiscal year 2023 is expected to be in the range of
to$4.15 , equating to growth of between$4.55 4% to14% year-on-year, despite the significantly strongerU.S. dollar, higher borrowing costs, weakening global economic demand conditions, and one less week in fiscal 2023; -
Operating cash flow in fiscal year 2023 is expected to be between
and$300 million , being more weighted to the second half of the year, and capital expenditures are expected to be$350 million .$120 million
Conference Call:
The company will hold a conference call on
Regulation G
The information presented in this earnings release regarding consolidated and segment organic revenue growth, operating income, adjusted gross profit, adjusted gross profit margin, adjusted selling, general and administrative expense, adjusted income before income taxes and income from equity investments, adjusted income taxes, adjusted effective tax rate, adjusted net income, adjusted diluted earnings per share and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) does not conform to
About
Since 1887,
Safe Harbor for Forward-Looking Statements
Certain statements in this press release may be considered forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” "target," “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases. These statements are subject to various risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including but not limited to the following: the consequences of the COVID-19 outbreak and other pandemics on our operations and financial results; the impact on the supply chain, raw material costs and pricing of our products due to the
Additional information about these various risks and uncertainties can be found in the “Risk Factors” section of our Form 10-K filings, and any updates to the risk factors in our Form 10-Q and 8-K filings with the
H.B. FULLER COMPANY AND SUBSIDIARIES |
CONSOLIDATED FINANCIAL INFORMATION |
In thousands, except per share amounts (unaudited) |
|
|
Three Months
|
|
|
|
|
Three Months
|
|
|
|
||||||
|
|
|
|
|
Percent of
|
|
|
|
|
|
Percent of
|
|
||||
Net revenue |
|
$ |
958,213 |
|
|
|
100.0 |
% |
|
$ |
897,424 |
|
|
|
100.0 |
% |
Cost of sales |
|
|
(710,092 |
) |
|
|
(74.1 |
)% |
|
|
(655,965 |
) |
|
|
(73.1 |
)% |
Gross profit |
|
|
248,121 |
|
|
|
25.9 |
% |
|
|
241,459 |
|
|
|
26.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
(157,872 |
) |
|
|
(16.5 |
)% |
|
|
(165,789 |
) |
|
|
(18.5 |
)% |
Other income, net |
|
|
251 |
|
|
|
0.0 |
% |
|
|
6,954 |
|
|
|
0.8 |
% |
Interest expense |
|
|
(30,046 |
) |
|
|
(3.1 |
)% |
|
|
(18,392 |
) |
|
|
(2.0 |
)% |
Interest income |
|
|
1,609 |
|
|
|
0.2 |
% |
|
|
1,767 |
|
|
|
0.2 |
% |
Income before income taxes and income from equity method investments |
|
|
62,063 |
|
|
|
6.5 |
% |
|
|
65,999 |
|
|
|
7.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes |
|
|
(15,163 |
) |
|
|
(1.6 |
)% |
|
|
(16,671 |
) |
|
|
(1.9 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from equity method investments |
|
|
1,429 |
|
|
|
0.1 |
% |
|
|
1,587 |
|
|
|
0.2 |
% |
Net income including non-controlling interest |
|
|
48,329 |
|
|
|
5.0 |
% |
|
|
50,915 |
|
|
|
5.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to non-controlling interest |
|
|
(24 |
) |
|
|
(0.0 |
)% |
|
|
(31 |
) |
|
|
(0.0 |
)% |
Net income attributable to |
|
$ |
48,305 |
|
|
|
5.0 |
% |
|
$ |
50,884 |
|
|
|
5.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income per common share attributable to |
|
$ |
0.90 |
|
|
|
|
|
|
$ |
0.96 |
|
|
|
|
|
Diluted income per common share attributable to |
|
$ |
0.87 |
|
|
|
|
|
|
$ |
0.93 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
53,824 |
|
|
|
|
|
|
|
53,168 |
|
|
|
|
|
Diluted |
|
|
55,472 |
|
|
|
|
|
|
|
54,980 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share |
|
$ |
0.190 |
|
|
|
|
|
|
$ |
0.168 |
|
|
|
|
|
H.B. FULLER COMPANY AND SUBSIDIARIES |
CONSOLIDATED FINANCIAL INFORMATION |
In thousands, except per share amounts (unaudited) |
|
|
Year Ended |
|
|
|
|
Year Ended |
|
|
|
||||||
|
|
|
|
|
Percent of
|
|
|
|
|
|
Percent of
|
|
||||
Net revenue |
|
$ |
3,749,183 |
|
|
|
100.0 |
% |
|
$ |
3,278,031 |
|
|
|
100.0 |
% |
Cost of sales |
|
|
(2,785,484 |
) |
|
|
(74.3 |
)% |
|
|
(2,432,709 |
) |
|
|
(74.2 |
)% |
Gross profit |
|
|
963,699 |
|
|
|
25.7 |
% |
|
|
845,322 |
|
|
|
25.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
(640,981 |
) |
|
|
(17.1 |
)% |
|
|
(592,710 |
) |
|
|
(18.1 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income, net |
|
|
12,952 |
|
|
|
0.3 |
% |
|
|
32,855 |
|
|
|
1.0 |
% |
Interest expense |
|
|
(91,521 |
) |
|
|
(2.4 |
)% |
|
|
(78,092 |
) |
|
|
(2.4 |
)% |
Interest income |
|
|
7,779 |
|
|
|
0.2 |
% |
|
|
9,476 |
|
|
|
0.3 |
% |
Income before income taxes and income from equity method investments |
|
|
251,928 |
|
|
|
6.7 |
% |
|
|
216,851 |
|
|
|
6.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes |
|
|
(77,186 |
) |
|
|
(2.1 |
)% |
|
|
(63,033 |
) |
|
|
(1.9 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from equity method investments |
|
|
5,665 |
|
|
|
0.2 |
% |
|
|
7,657 |
|
|
|
0.2 |
% |
Net income including non-controlling interest |
|
|
180,407 |
|
|
|
4.8 |
% |
|
|
161,475 |
|
|
|
4.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to non-controlling interest |
|
|
(94 |
) |
|
|
(0.0 |
)% |
|
|
(82 |
) |
|
|
(0.0 |
)% |
Net income attributable to |
|
$ |
180,313 |
|
|
|
4.8 |
% |
|
$ |
161,393 |
|
|
|
4.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income per common share attributable to |
|
$ |
3.37 |
|
|
|
|
|
|
$ |
3.05 |
|
|
|
|
|
Diluted income per common share attributable to |
|
$ |
3.26 |
|
|
|
|
|
|
$ |
2.97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
53,580 |
|
|
|
|
|
|
|
52,887 |
|
|
|
|
|
Diluted |
|
|
55,269 |
|
|
|
|
|
|
|
54,315 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share |
|
$ |
0.738 |
|
|
|
|
|
|
$ |
0.665 |
|
|
|
|
|
H.B. FULLER COMPANY AND SUBSIDIARIES REGULATION G RECONCILIATION In thousands, except per share amounts (unaudited) |
|||||||||||||
|
|
Three Months Ended |
Year Ended |
||||||||||
|
|
|
|
|
|||||||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to |
|
$ |
48,305 |
|
$ |
50,884 |
|
$ |
180,313 |
|
$ |
161,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
1,822 |
|
|
3,344 |
|
|
10,830 |
|
|
5,622 |
|
Organizational realignment 2 |
|
|
1,471 |
|
|
3,670 |
|
|
6,386 |
|
|
12,699 |
|
Royal restructuring and integration 3 |
|
|
1,467 |
|
|
658 |
|
|
2,474 |
|
|
4,195 |
|
Project One |
|
|
2,326 |
|
|
2,958 |
|
|
9,885 |
|
|
9,426 |
|
Other 4 |
|
|
4,524 |
|
|
3,554 |
|
|
12,791 |
|
|
(146 |
) |
Discrete tax items 5 |
|
|
1,610 |
|
|
(796 |
) |
|
9,308 |
|
|
4,272 |
|
Income tax effect on adjustments 6 |
|
|
(3,911 |
) |
|
(4,511 |
) |
|
(10,699 |
) |
|
(8,872 |
) |
Adjusted net income attributable to |
|
|
57,614 |
|
|
59,761 |
|
|
221,288 |
|
|
188,589 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
30,046 |
|
|
18,406 |
|
|
91,547 |
|
|
78,175 |
|
Interest income |
|
|
(1,609 |
) |
|
(1,767 |
) |
|
(7,790 |
) |
|
(9,476 |
) |
Income taxes |
|
|
17,464 |
|
|
21,978 |
|
|
78,576 |
|
|
67,632 |
|
Depreciation and Amortization expense 8 |
|
|
37,469 |
|
|
35,407 |
|
|
146,394 |
|
|
142,003 |
|
Adjusted EBITDA 7 |
|
|
140,984 |
|
|
133,785 |
|
|
530,015 |
|
|
466,923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Shares |
|
|
55,472 |
|
|
54,980 |
|
|
55,269 |
|
|
54,315 |
|
Adjusted diluted income per common share attributable to |
|
$ |
1.04 |
|
$ |
1.09 |
|
$ |
4.00 |
|
$ |
3.47 |
|
Net revenue |
|
$ |
958,213 |
|
$ |
897,424 |
|
$ |
3,749,183 |
|
$ |
3,278,031 |
|
Adjusted EBITDA margin 7 |
|
|
14.7 |
% |
|
14.9 |
% |
|
14.1 |
% |
|
14.2 |
% |
1 Acquisition project costs include costs related to integrating and accounting for acquisitions. |
2 Organizational realignment includes costs incurred as a direct result of the organizational realignment program, including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities. |
3 Royal restructuring and integration program includes costs incurred as a direct result of the Royal restructuring and integration program including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities. |
4 Other expenses, for the fiscal year ended |
5 Discrete tax items are related to revaluation of cross-currency swap agreements due to depreciation of the Euro versus the |
6 Represents the difference between income taxes on net income before income taxes and income from equity method investments reported in accordance with |
7 Adjusted net income attributable to |
8 Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in Adjusted net income attributable to |
H.B. FULLER COMPANY AND SUBSIDIARIES SEGMENT FINANCIAL INFORMATION In thousands (unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
Year Ended |
|
|||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
|||||||
Net Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hygiene, Health and Consumable Adhesives |
|
$ |
443,528 |
|
|
$ |
402,834 |
|
|
$ |
1,695,934 |
|
|
$ |
1,472,756 |
|
Engineering Adhesives |
|
|
395,053 |
|
|
|
371,419 |
|
|
|
1,532,639 |
|
|
|
1,371,756 |
|
Construction Adhesives |
|
|
119,632 |
|
|
|
123,171 |
|
|
|
520,610 |
|
|
|
433,519 |
|
Corporate unallocated |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Total |
|
$ |
958,213 |
|
|
$ |
897,424 |
|
|
$ |
3,749,183 |
|
|
$ |
3,278,031 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Operating Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hygiene, Health and Consumable Adhesives |
|
$ |
42,836 |
|
|
$ |
39,874 |
|
|
$ |
165,786 |
|
|
$ |
138,366 |
|
Engineering Adhesives |
|
|
53,607 |
|
|
|
39,333 |
|
|
|
168,873 |
|
|
|
135,913 |
|
Construction Adhesives |
|
|
957 |
|
|
|
9,174 |
|
|
|
22,989 |
|
|
|
14,148 |
|
Corporate unallocated |
|
|
(7,151 |
) |
|
|
(12,711 |
) |
|
|
(34,930 |
) |
|
|
(35,815 |
) |
Total |
|
$ |
90,249 |
|
|
$ |
75,670 |
|
|
$ |
322,718 |
|
|
$ |
252,612 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA 7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hygiene, Health and Consumable Adhesives |
|
$ |
57,684 |
|
|
$ |
54,808 |
|
|
$ |
223,988 |
|
|
$ |
197,479 |
|
Engineering Adhesives |
|
|
70,487 |
|
|
|
57,097 |
|
|
|
235,948 |
|
|
|
207,131 |
|
Construction Adhesives |
|
|
14,571 |
|
|
|
20,105 |
|
|
|
74,187 |
|
|
|
57,890 |
|
Corporate unallocated |
|
|
(1,758 |
) |
|
|
1,775 |
|
|
|
(4,108 |
) |
|
|
4,423 |
|
Total |
|
$ |
140,984 |
|
|
$ |
133,785 |
|
|
$ |
530,015 |
|
|
$ |
466,923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA Margin 7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hygiene, Health and Consumable Adhesives |
|
|
13.0 |
% |
|
|
13.6 |
% |
|
|
13.2 |
% |
|
|
13.4 |
% |
Engineering Adhesives |
|
|
17.8 |
% |
|
|
15.4 |
% |
|
|
15.4 |
% |
|
|
15.1 |
% |
Construction Adhesives |
|
|
12.2 |
% |
|
|
16.3 |
% |
|
|
14.3 |
% |
|
|
13.4 |
% |
Corporate unallocated |
|
NMP |
|
|
NMP |
|
|
NMP |
|
|
NMP |
|
||||
Total |
|
|
14.7 |
% |
|
|
14.9 |
% |
|
|
14.1 |
% |
|
|
14.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NMP = non-meaningful percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H.B. FULLER COMPANY AND SUBSIDIARIES REGULATION G RECONCILIATION In thousands, except per share amounts (unaudited) |
|||||||||||||
|
|
Three Months Ended |
|
Year Ended |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes and income from equity method investments |
|
$ |
62,063 |
|
$ |
65,999 |
|
$ |
251,928 |
|
$ |
216,851 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
1,822 |
|
|
3,344 |
|
|
10,830 |
|
|
5,622 |
|
Organizational realignment 2 |
|
|
1,471 |
|
|
3,670 |
|
|
6,386 |
|
|
12,699 |
|
Royal restructuring and integration 3 |
|
|
1,467 |
|
|
658 |
|
|
2,474 |
|
|
4,195 |
|
Project One |
|
|
2,326 |
|
|
2,958 |
|
|
9,885 |
|
|
9,426 |
|
Other 4 |
|
|
4,524 |
|
|
3,554 |
|
|
12,791 |
|
|
(146 |
) |
Adjusted income before income taxes and income from equity method investments 9 |
|
$ |
73,673 |
|
$ |
80,183 |
|
$ |
294,294 |
|
$ |
248,647 |
|
9 Adjusted income before income taxes and income from equity investments is a non-GAAP financial measure. Adjusted income before income taxes and income from equity investments is defined as income before income taxes and income from equity investments before the specific adjustments shown above. The table above provides a reconciliation of adjusted income before income taxes and income from equity investments to income before income taxes and income from equity investments, the most directly comparable financial measure determined and reported in accordance with |
H.B. FULLER COMPANY AND SUBSIDIARIES REGULATION G RECONCILIATION In thousands, except per share amounts (unaudited) |
|||||||||||||
|
|
Three Months Ended |
|
Year Ended |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Taxes |
|
$ |
(15,163 |
) |
$ |
(16,671 |
) |
$ |
(77,186 |
) |
$ |
(63,033 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
(613 |
) |
|
(1,064 |
) |
|
(2,767 |
) |
|
(1,559 |
) |
Organizational realignment 2 |
|
|
(495 |
) |
|
(1,167 |
) |
|
(1,635 |
) |
|
(3,372 |
) |
Royal restructuring and integration 3 |
|
|
(494 |
) |
|
(209 |
) |
|
(707 |
) |
|
(1,055 |
) |
Project One |
|
|
(783 |
) |
|
(940 |
) |
|
(2,067 |
) |
|
(2,492 |
) |
Other 4 |
|
|
84 |
|
|
(1,927 |
) |
|
5,786 |
|
|
3,879 |
|
Adjusted income taxes 10 |
|
$ |
(17,464 |
) |
$ |
(21,978 |
) |
$ |
(78,576 |
) |
$ |
(67,632 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income before income taxes and income from equity method investments |
|
$ |
73,673 |
|
$ |
80,183 |
|
$ |
294,294 |
|
$ |
248,647 |
|
Adjusted effective income tax rate 10 |
|
|
23.7 |
% |
|
27.4 |
% |
|
26.7 |
% |
|
27.2 |
% |
10 Adjusted income taxes and adjusted effective income tax rate are non-GAAP financial measures. Adjusted income taxes is defined as income taxes before the specific adjustments shown above. Adjusted effective income tax rate is defined as income taxes divided by adjusted income before income taxes and income from equity method investments. The table above provides a reconciliation of adjusted income taxes and adjusted effective income tax rate to income taxes, the most directly comparable financial measure determined and reported in accordance with |
H.B. FULLER COMPANY AND SUBSIDIARIES REGULATION G RECONCILIATION In thousands (unaudited) |
|||||||||||||
|
|
Three Months Ended |
|
Year Ended |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue |
|
$ |
958,213 |
|
$ |
897,424 |
|
$ |
3,749,183 |
|
$ |
3,278,031 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
248,121 |
|
$ |
241,459 |
|
$ |
963,699 |
|
$ |
845,322 |
|
Gross profit margin |
|
|
25.9 |
% |
|
26.9 |
% |
|
25.7 |
% |
|
25.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
738 |
|
|
156 |
|
|
1,058 |
|
|
219 |
|
Organizational realignment 2 |
|
|
1,211 |
|
|
1,585 |
|
|
3,207 |
|
|
3,851 |
|
Royal restructuring and integration 3 |
|
|
329 |
|
|
138 |
|
|
706 |
|
|
2,100 |
|
Project ONE |
|
|
- |
|
|
- |
|
|
6 |
|
|
(22 |
) |
Other 4 |
|
|
472 |
|
|
204 |
|
|
1,830 |
|
|
1,839 |
|
Adjusted gross profit 11 |
|
$ |
250,871 |
|
$ |
243,542 |
|
$ |
970,506 |
|
$ |
853,309 |
|
Adjusted gross profit margin 11 |
|
|
26.2 |
% |
|
27.1 |
% |
|
25.9 |
% |
|
26.0 |
% |
11 Adjusted gross profit and adjusted gross profit margin are non-GAAP financial measures. Adjusted gross profit and adjusted gross profit margin is defined as gross profit and gross profit margin excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted gross profit and gross profit margin to gross profit and gross profit margin, the most directly comparable financial measure determined and reported in accordance with |
H.B. FULLER COMPANY AND SUBSIDIARIES REGULATION G RECONCILIATION In thousands (unaudited) |
|||||||||||||
|
|
Three Months Ended |
|
Year Ended |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
$ |
(157,872 |
) |
$ |
(165,789 |
) |
$ |
(640,981 |
) |
$ |
(592,710 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
1,084 |
|
|
3,189 |
|
|
9,772 |
|
|
5,402 |
|
Organizational realignment 2 |
|
|
260 |
|
|
1,420 |
|
|
4,393 |
|
|
8,239 |
|
Royal restructuring and integration 3 |
|
|
1,138 |
|
|
533 |
|
|
1,794 |
|
|
2,177 |
|
Project ONE |
|
|
2,326 |
|
|
2,957 |
|
|
9,879 |
|
|
9,449 |
|
Other 4 |
|
|
(408 |
) |
|
2,529 |
|
|
2,284 |
|
|
2,561 |
|
Adjusted selling, general and administrative expenses 12 |
|
$ |
(153,472 |
) |
$ |
(155,161 |
) |
$ |
(612,859 |
) |
$ |
(564,882 |
) |
12 Adjusted selling, general and administrative expenses is a non-GAAP financial measure. Adjusted selling, general and administrative expenses is defined as selling, general and administrative expenses excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted selling, general and administrative expenses to selling, general and administrative expenses, the most directly comparable financial measure determined and reported in accordance with |
H.B. FULLER COMPANY AND SUBSIDIARIES REGULATION G RECONCILIATION In thousands (unaudited) |
||||||||||||||||||||||||
|
|
Hygiene, Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Three Months Ended |
|
and Consumable |
|
Engineering |
|
Construction |
|
|
|
|
|
Corporate |
|
|
||||||||||
|
|
Adhesives |
|
Adhesives |
|
Adhesives |
|
Total |
|
Unallocated |
|
Consolidated |
||||||||||||
Net income attributable to |
|
$ |
45,913 |
|
|
$ |
55,900 |
|
|
$ |
3,460 |
|
|
$ |
105,273 |
|
|
$ |
(56,968 |
) |
|
$ |
48,305 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,822 |
|
|
|
1,822 |
|
Organizational realignment 2 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,471 |
|
|
|
1,471 |
|
Royal restructuring and integration 3 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,467 |
|
|
|
1,467 |
|
Project One |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,326 |
|
|
|
2,326 |
|
Other 4 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
4,524 |
|
|
|
4,524 |
|
Discrete tax items 5 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,610 |
|
|
|
1,610 |
|
Income tax effect on adjustments 6 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(3,911 |
) |
|
|
(3,911 |
) |
Adjusted net income attributable to |
|
|
45,913 |
|
|
|
55,900 |
|
|
|
3,460 |
|
|
|
105,273 |
|
|
|
(47,659 |
) |
|
|
57,614 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
30,046 |
|
|
|
30,046 |
|
Interest income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,609 |
) |
|
|
(1,609 |
) |
Income taxes |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
17,464 |
|
|
|
17,464 |
|
Depreciation and amortization expense 8 |
|
|
11,771 |
|
|
|
14,587 |
|
|
|
11,111 |
|
|
|
37,469 |
|
|
|
- |
|
|
|
37,469 |
|
Adjusted EBITDA 7 |
|
$ |
57,684 |
|
|
$ |
70,487 |
|
|
$ |
14,571 |
|
|
$ |
142,742 |
|
|
$ |
(1,758 |
) |
|
$ |
140,984 |
|
Net revenue |
|
$ |
443,528 |
|
|
$ |
395,053 |
|
|
$ |
119,632 |
|
|
$ |
958,213 |
|
|
|
- |
|
|
$ |
958,213 |
|
Adjusted EBITDA margin 7 |
|
|
13.0 |
% |
|
|
17.8 |
% |
|
|
12.2 |
% |
|
|
14.9 |
% |
|
NMP |
|
|
|
14.7 |
% |
|
|
Hygiene, Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Year Ended |
|
and Consumable |
|
Engineering |
|
Construction |
|
|
|
|
|
Corporate |
|
|
||||||||||
|
|
Adhesives |
|
Adhesives |
|
Adhesives |
|
Total |
|
Unallocated |
|
Consolidated |
||||||||||||
Net income attributable to |
|
$ |
177,614 |
|
|
$ |
177,641 |
|
|
$ |
32,474 |
|
|
$ |
387,729 |
|
|
$ |
(207,416 |
) |
|
$ |
180,313 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
10,830 |
|
|
|
10,830 |
|
Organizational realignment 2 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
6,386 |
|
|
|
6,386 |
|
Royal restructuring and integration 3 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,474 |
|
|
|
2,474 |
|
Project One |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
9,885 |
|
|
|
9,885 |
|
Other 4 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
12,791 |
|
|
|
12,791 |
|
Discrete tax items 5 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
9,308 |
|
|
|
9,308 |
|
Income tax effect on adjustments 6 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(10,699 |
) |
|
|
(10,699 |
) |
Adjusted net income attributable to |
|
|
177,614 |
|
|
|
177,641 |
|
|
|
32,474 |
|
|
|
387,729 |
|
|
|
(166,441 |
) |
|
|
221,288 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
91,547 |
|
|
|
91,547 |
|
Interest income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(7,790 |
) |
|
|
(7,790 |
) |
Income taxes |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
78,576 |
|
|
|
78,576 |
|
Depreciation and amortization expense 8 |
|
|
46,374 |
|
|
|
58,307 |
|
|
|
41,713 |
|
|
|
146,394 |
|
|
|
- |
|
|
|
146,394 |
|
Adjusted EBITDA 7 |
|
$ |
223,988 |
|
|
$ |
235,948 |
|
|
$ |
74,187 |
|
|
$ |
534,123 |
|
|
$ |
(4,108 |
) |
|
$ |
530,015 |
|
Net revenue |
|
|
1,695,934 |
|
|
|
1,532,639 |
|
|
|
520,610 |
|
|
$ |
3,749,183 |
|
|
|
- |
|
|
|
3,749,183 |
|
Adjusted EBITDA margin 7 |
|
|
13.2 |
% |
|
|
15.4 |
% |
|
|
14.3 |
% |
|
|
14.2 |
% |
|
NMP |
|
|
|
14.1 |
% |
Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to |
NMP = Non-meaningful percentage |
H.B. FULLER COMPANY AND SUBSIDIARIES REGULATION G RECONCILIATION In thousands (unaudited) |
||||||||||||||||||||||||
|
|
Hygiene, Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Three Months Ended |
|
and Consumable |
|
Engineering |
|
Construction |
|
|
|
|
|
Corporate |
|
|
||||||||||
|
|
Adhesives |
|
Adhesives |
|
Adhesives |
|
Total |
|
Unallocated |
|
Consolidated |
||||||||||||
Net income attributable to |
|
$ |
43,269 |
|
|
$ |
41,950 |
|
|
$ |
11,384 |
|
|
$ |
96,603 |
|
|
$ |
(45,719 |
) |
|
$ |
50,884 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
3,344 |
|
|
|
3,344 |
|
Organizational realignment 2 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
3,670 |
|
|
|
3,670 |
|
Royal restructuring and integration 3 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
658 |
|
|
|
658 |
|
Project One |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,958 |
|
|
|
2,958 |
|
Other 4 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
3,554 |
|
|
|
3,554 |
|
Discrete tax items 5 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(796 |
) |
|
|
(796 |
) |
Income tax effect on adjustments 6 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(4,511 |
) |
|
|
(4,511 |
) |
Adjusted net income attributable to |
|
|
43,269 |
|
|
|
41,950 |
|
|
|
11,384 |
|
|
|
96,603 |
|
|
|
(36,842 |
) |
|
|
59,761 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
18,406 |
|
|
|
18,406 |
|
Interest income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,767 |
) |
|
|
(1,767 |
) |
Income taxes |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
21,978 |
|
|
|
21,978 |
|
Depreciation and amortization expense 8 |
|
|
11,539 |
|
|
|
15,147 |
|
|
|
8,721 |
|
|
|
35,407 |
|
|
|
- |
|
|
|
35,407 |
|
Adjusted EBITDA 7 |
|
$ |
54,808 |
|
|
$ |
57,097 |
|
|
$ |
20,105 |
|
|
$ |
132,010 |
|
|
$ |
1,775 |
|
|
$ |
133,785 |
|
Net revenue |
|
$ |
402,834 |
|
|
$ |
371,419 |
|
|
$ |
123,171 |
|
|
$ |
897,424 |
|
|
|
- |
|
|
$ |
897,424 |
|
Adjusted EBITDA margin 7 |
|
|
13.6 |
% |
|
|
15.4 |
% |
|
|
16.3 |
% |
|
|
14.7 |
% |
|
NMP |
|
|
|
14.9 |
% |
|
|
Hygiene, Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Year Ended |
|
and Consumable |
|
Engineering |
|
Construction |
|
|
|
|
|
Corporate |
|
|
||||||||||
|
|
Adhesives |
|
Adhesives |
|
Adhesives |
|
Total |
|
Unallocated |
|
Consolidated |
||||||||||||
Net income attributable to |
|
$ |
151,560 |
|
|
$ |
146,050 |
|
|
$ |
22,887 |
|
|
$ |
320,497 |
|
|
$ |
(159,104 |
) |
|
$ |
161,393 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs 1 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
5,622 |
|
|
|
5,622 |
|
Organizational realignment 2 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
12,699 |
|
|
|
12,699 |
|
Royal restructuring and integration 3 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
4,195 |
|
|
|
4,195 |
|
Project One |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
9,426 |
|
|
|
9,426 |
|
Other 4 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(146 |
) |
|
|
(146 |
) |
Discrete tax items 5 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
4,272 |
|
|
|
4,272 |
|
Income tax effect on adjustments 6 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(8,872 |
) |
|
|
(8,872 |
) |
Adjusted net income attributable to |
|
|
151,560 |
|
|
|
146,050 |
|
|
|
22,887 |
|
|
|
320,497 |
|
|
|
(131,908 |
) |
|
|
188,589 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
78,175 |
|
|
|
78,175 |
|
Interest income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(9,476 |
) |
|
|
(9,476 |
) |
Income taxes |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
67,632 |
|
|
|
67,632 |
|
Depreciation and amortization expense 8 |
|
|
45,919 |
|
|
|
61,081 |
|
|
|
35,003 |
|
|
|
142,003 |
|
|
|
- |
|
|
|
142,003 |
|
Adjusted EBITDA 7 |
|
$ |
197,479 |
|
|
$ |
207,131 |
|
|
$ |
57,890 |
|
|
$ |
462,500 |
|
|
$ |
4,423 |
|
|
$ |
466,923 |
|
Net revenue |
|
$ |
1,472,756 |
|
|
$ |
1,371,756 |
|
|
$ |
433,519 |
|
|
$ |
3,278,031 |
|
|
|
- |
|
|
$ |
3,278,031 |
|
Adjusted EBITDA margin 7 |
|
|
13.4 |
% |
|
|
15.1 |
% |
|
|
13.4 |
% |
|
|
14.1 |
% |
|
NMP |
|
|
|
14.2 |
% |
Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to |
NMP = Non-meaningful percentage |
H.B. FULLER COMPANY AND SUBSIDIARIES SEGMENT FINANCIAL INFORMATION NET REVENUE GROWTH (DECLINE) (unaudited) |
||||||||
Net revenue growth versus 2021 |
|
|
Three Months Ended |
|
|
|
Year Ended |
|
|
|
|
|
|
|
|
||
Price |
|
|
11.4 |
% |
|
|
15.4 |
% |
Volume |
|
|
(5.0 |
)% |
|
|
1.2 |
% |
Organic Growth 13 |
|
|
6.4 |
% |
|
|
16.6 |
% |
|
|
|
7.5 |
% |
|
|
2.0 |
% |
M&A |
|
|
1.6 |
% |
|
|
1.6 |
% |
Constant Currency |
|
|
15.5 |
% |
|
|
20.2 |
% |
F/X |
|
|
(8.7 |
)% |
|
|
(5.8 |
)% |
Total H.B. Fuller Net Revenue Growth |
|
|
6.8 |
% |
|
|
14.4 |
% |
Net revenue growth versus 2021 |
|
Three Months Ended |
|
|||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
Net Revenue |
|
|
F/X |
|
|
Constant Currency |
|
|
M&A |
|
|
(53 week year) |
|
|
Organic Growth 13 |
|
||||||
Hygiene, Health and Consumable Adhesives |
|
|
10.1 |
% |
|
|
(10.0 |
)% |
|
|
20.1 |
% |
|
|
0.0 |
% |
|
|
7.7 |
% |
|
|
12.4 |
% |
Engineering Adhesives |
|
|
6.4 |
% |
|
|
(9.6 |
)% |
|
|
16.0 |
% |
|
|
0.0 |
% |
|
|
7.5 |
% |
|
|
8.5 |
% |
Construction Adhesives |
|
|
(2.9 |
)% |
|
|
(1.8 |
)% |
|
|
(1.1 |
)% |
|
|
11.9 |
% |
|
|
6.6 |
% |
|
|
(19.6 |
)% |
Total |
|
|
6.8 |
% |
|
|
(8.7 |
)% |
|
|
15.5 |
% |
|
|
1.6 |
% |
|
|
7.5 |
% |
|
|
6.4 |
% |
Net revenue growth versus 2021 |
|
Year Ended |
|
|||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
Net Revenue |
|
|
F/X |
|
|
Constant Currency |
|
|
M&A |
|
|
(53 week year) |
|
|
Organic Growth 13 |
|
||||||
Hygiene, Health and Consumable Adhesives |
|
|
15.2 |
% |
|
|
(6.9 |
)% |
|
|
22.1 |
% |
|
|
0.0 |
% |
|
|
2.1 |
% |
|
|
20.0 |
% |
Engineering Adhesives |
|
|
11.7 |
% |
|
|
(6.2 |
)% |
|
|
17.9 |
% |
|
|
0.0 |
% |
|
|
2.0 |
% |
|
|
15.9 |
% |
Construction Adhesives |
|
|
20.1 |
% |
|
|
(1.2 |
)% |
|
|
21.3 |
% |
|
|
12.4 |
% |
|
|
1.9 |
% |
|
|
7.0 |
% |
Total |
|
|
14.4 |
% |
|
|
(5.8 |
)% |
|
|
20.2 |
% |
|
|
1.6 |
% |
|
|
2.0 |
% |
|
|
16.6 |
% |
13 We use the term “organic revenue” to refer to net revenue, excluding the effect of foreign currency changes and acquisitions and divestitures. Organic growth reflects adjustments for the impact of period-over-period changes in foreign currency exchange rates on revenues, the revenues associated with acquisitions and divestitures and the revenues associated with an extra week in 2022 as it was a 53 week year.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts) |
||||||||
|
|
|
|
|
|
|
||
|
|
2022 |
|
|
2021 |
|
||
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
79,910 |
|
|
$ |
61,786 |
|
Trade receivables, net |
|
|
607,365 |
|
|
|
614,645 |
|
Inventories |
|
|
491,781 |
|
|
|
448,404 |
|
Other current assets |
|
|
120,319 |
|
|
|
96,335 |
|
Total current assets |
|
|
1,299,375 |
|
|
|
1,221,170 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
733,667 |
|
|
|
695,367 |
|
|
|
|
1,392,627 |
|
|
|
1,298,845 |
|
Other intangibles, net |
|
|
702,092 |
|
|
|
687,075 |
|
Other assets |
|
|
335,868 |
|
|
|
372,073 |
|
Total assets |
|
$ |
4,463,629 |
|
|
$ |
4,274,530 |
|
|
|
|
|
|
|
|
|
|
Liabilities, non-controlling interest and total equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Notes payable |
|
$ |
28,860 |
|
|
$ |
24,983 |
|
Current maturities of long-term debt |
|
|
- |
|
|
|
- |
|
Trade payables |
|
|
460,669 |
|
|
|
500,321 |
|
Accrued compensation |
|
|
108,328 |
|
|
|
109,542 |
|
Income taxes payable |
|
|
18,530 |
|
|
|
15,943 |
|
Other accrued expenses |
|
|
89,345 |
|
|
|
86,061 |
|
Total current liabilities |
|
|
705,732 |
|
|
|
736,850 |
|
|
|
|
|
|
|
|
|
|
Long-term debt, net of current maturities |
|
|
1,736,256 |
|
|
|
1,591,479 |
|
Accrued pension liabilities |
|
|
52,561 |
|
|
|
71,651 |
|
Other liabilities |
|
|
358,286 |
|
|
|
277,190 |
|
Total liabilities |
|
|
2,852,835 |
|
|
|
2,677,170 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock (no shares outstanding) Shares authorized – 10,045,900 |
|
|
- |
|
|
|
- |
|
Common stock, par value |
|
|
53,677 |
|
|
|
52,778 |
|
Additional paid-in capital |
|
|
266,491 |
|
|
|
213,637 |
|
Retained earnings |
|
|
1,741,359 |
|
|
|
1,600,601 |
|
Accumulated other comprehensive loss |
|
|
(451,357 |
) |
|
|
(270,247 |
) |
Total |
|
|
1,610,170 |
|
|
|
1,596,769 |
|
Non-controlling interest |
|
|
624 |
|
|
|
591 |
|
Total equity |
|
|
1,610,794 |
|
|
|
1,597,360 |
|
Total liabilities, non-controlling interest and total equity |
|
$ |
4,463,629 |
|
|
$ |
4,274,530 |
|
CONSOLIDATED STATEMENTS of CASH FLOWS
(In thousands) |
||||||||||||
|
|
Fiscal Years |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
2022 |
|
|
2021 |
|
|
2020 |
|
|||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income including non-controlling interest |
|
$ |
180,407 |
|
|
$ |
161,475 |
|
|
$ |
123,788 |
|
Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
|
72,593 |
|
|
|
72,106 |
|
|
|
68,226 |
|
Amortization |
|
|
74,383 |
|
|
|
71,068 |
|
|
|
70,591 |
|
Deferred income taxes |
|
|
(15,230 |
) |
|
|
16,192 |
|
|
|
(24,730 |
) |
Income from equity method investments, net of dividends received |
|
|
(9 |
) |
|
|
2,776 |
|
|
|
375 |
|
(Gain) loss on sale of assets |
|
|
(1,195 |
) |
|
|
648 |
|
|
|
86 |
|
Share-based compensation |
|
|
24,368 |
|
|
|
22,366 |
|
|
|
16,914 |
|
Pension and other postretirement benefit plan contributions |
|
|
(3,009 |
) |
|
|
(3,840 |
) |
|
|
(5,479 |
) |
Pension and other postretirement benefit plan income |
|
|
(24,021 |
) |
|
|
(28,662 |
) |
|
|
(14,763 |
) |
Mark to market adjustment related to contingent consideration liabilities |
|
|
- |
|
|
|
2,300 |
|
|
|
800 |
|
Change in assets and liabilities, net of effects of acquisitions: |
|
|
|
|
|
|
|
|
|
|
|
|
Trade receivables, net |
|
|
(24,753 |
) |
|
|
(124,849 |
) |
|
|
(14,842 |
) |
Inventories |
|
|
(55,772 |
) |
|
|
(135,351 |
) |
|
|
15,708 |
|
Other assets |
|
|
46,499 |
|
|
|
(79,097 |
) |
|
|
38,412 |
|
Trade payables |
|
|
(22,629 |
) |
|
|
176,337 |
|
|
|
23,130 |
|
Accrued compensation |
|
|
1,135 |
|
|
|
27,741 |
|
|
|
2,588 |
|
Other accrued expenses |
|
|
6,303 |
|
|
|
1,186 |
|
|
|
16,361 |
|
Income taxes payable |
|
|
(12,873 |
) |
|
|
(4,137 |
) |
|
|
5,511 |
|
Other liabilities |
|
|
4,104 |
|
|
|
(73,508 |
) |
|
|
24,566 |
|
Other |
|
|
6,213 |
|
|
|
108,566 |
|
|
|
(15,683 |
) |
Net cash provided by operating activities |
|
|
256,514 |
|
|
|
213,317 |
|
|
|
331,559 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Purchased property, plant and equipment |
|
|
(129,964 |
) |
|
|
(96,089 |
) |
|
|
(87,288 |
) |
Purchased businesses, net of cash acquired |
|
|
(250,807 |
) |
|
|
(5,445 |
) |
|
|
(9,500 |
) |
Purchased business assets |
|
|
- |
|
|
|
- |
|
|
|
(5,623 |
) |
Proceeds from sale of property, plant and equipment |
|
|
1,556 |
|
|
|
2,896 |
|
|
|
1,506 |
|
Cash received from government grant |
|
|
3,928 |
|
|
|
5,800 |
|
|
|
- |
|
Cash outflow related to government grant |
|
|
- |
|
|
|
(1,822 |
) |
|
|
(8,555 |
) |
Net cash used in investing activities |
|
|
(375,287 |
) |
|
|
(94,660 |
) |
|
|
(109,460 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of long-term debt |
|
|
335,000 |
|
|
|
- |
|
|
|
300,000 |
|
Repayment of long-term debt |
|
|
(159,500 |
) |
|
|
(156,500 |
) |
|
|
(518,000 |
) |
Payment of debt issue costs |
|
|
(600 |
) |
|
|
- |
|
|
|
- |
|
Net proceeds from notes payable |
|
|
3,455 |
|
|
|
9,346 |
|
|
|
4,128 |
|
Dividends paid |
|
|
(39,207 |
) |
|
|
(34,859 |
) |
|
|
(33,461 |
) |
Contingent consideration payment |
|
|
(5,000 |
) |
|
|
(1,700 |
) |
|
|
(767 |
) |
Proceeds from stock options exercised |
|
|
30,122 |
|
|
|
32,325 |
|
|
|
12,321 |
|
Repurchases of common stock |
|
|
(3,950 |
) |
|
|
(2,682 |
) |
|
|
(3,432 |
) |
Net cash provided by (used in) financing activities |
|
|
160,320 |
|
|
|
(154,070 |
) |
|
|
(239,211 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
(23,423 |
) |
|
|
(3,335 |
) |
|
|
5,455 |
|
Net change in cash and cash equivalents |
|
|
18,124 |
|
|
|
(38,748 |
) |
|
|
(11,657 |
) |
Cash and cash equivalents at beginning of year |
|
|
61,786 |
|
|
|
100,534 |
|
|
|
112,191 |
|
Cash and cash equivalents at end of year |
|
$ |
79,910 |
|
|
$ |
61,786 |
|
|
$ |
100,534 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005293/en/
Investor Relations Contact
651-236-5060
Source:
FAQ
What were H.B. Fuller’s earnings results for FY 2022?
What is H.B. Fuller’s revenue outlook for fiscal year 2023?
How did foreign currency impacts affect H.B. Fuller’s financials?
What is H.B. Fuller’s adjusted EBITDA forecast for 2023?